PRENATAL DIAGNOSIS OF UNIPARENTAL DISOMY 15 FOLLOWING TRISOMY 15 MOSAICISM

Maternal uniparental disomy 15 (UPD15), responsible for approximately 25 per cent of Prader–Willi syndrome cases, is usually caused by maternal meiosis I non‐disjunction associated with advanced maternal age. These cases may initially be detected as mosaic trisomy 15 during routine prenatal diagnostic studies. In such cases, PCR (polymerase chain reaction) microsatellite analysis of uncultured cells makes prospective prenatal diagnosis for UPD15 possible with results available in 2–4 days. We have performed molecular analyses on a series of seven cases of mosaic trisomy 15 identified in amniotic fluid (AF, n=3) or chorionic villus samples (CVS, n=4) from patients initially referred for advanced maternal age or abnormal triple screen. In all cases, the maternal ages were ⩾35 years and maternal meiosis I non‐disjunction was documented as the cause of the trisomy in all informative cases (n=5). Of the three cases with mosaic trisomy 15 at amniocentesis, two showed the presence of the trisomy in the fetus. Molecular analysis showed one case with maternal UPD15 in the euploid cell line and one case with biparental inheritance. Both of these families elected to terminate the pregnancies based on the presence of true fetal mosaicism. In the third case, low‐level trisomy 15 mosaicism in the amniotic fluid was not confirmed in a follow‐up amniotic fluid sample and molecular analysis indicated biparental inheritance in the fetus. For the four trisomy 15 mosaics detected at CVS, molecular analysis was performed on direct amniotic fluid cell lysates for prospective diagnosis of UPD at 14–16 weeks' gestation. Follow‐up cytogenetic analysis of the amniotic fluid in all four cases was normal, indicating confined placental mosaicism. Molecular analysis showed one of these four cases to have maternal heterodisomy 15. Based on the likelihood of Prader–Willi syndrome due to maternal UPD15, the couple chose to terminate the pregnancy. The total of two of seven cases of trisomy 15 mosaicism resulting in UPD15 is consistent with the theoretical expectation of one‐third and indicates a high risk of UPD in such pregnancies. Therefore, UPD testing should be offered in all cases of mosaic trisomy 15 encountered in CVS or amniocentesis.

[1]  D. Ledbetter,et al.  Uniparental disomy in humans: development of an imprinting map and its implications for prenatal diagnosis. , 1995, Human molecular genetics.

[2]  J. Wolstenholme.  An audit of trisomy 16 in man , 1995, Prenatal diagnosis.

[3]  D. Kalousek,et al.  Genomic imprinting related to prenatal diagnosis , 1994, Prenatal diagnosis.

[4]  K. Sundberg,et al.  True trisomy 15 mosaicism, detected by amniocentesis at 12 weeks of gestation and fetal echocardiography , 1994, Prenatal diagnosis.

[5]  Cécile Fizames,et al.  The 1993–94 Généthon human genetic linkage map , 1994, Nature Genetics.

[6]  F. Torricelli,et al.  The predictive value of cytogenetic diagnosis after CVS based on 4860 cases with both direct and culture methods , 1994, Prenatal diagnosis.

[7]  L. Surh,et al.  Deletion and uniparental disomy involving the same maternal chromosome 15. , 1994, The New England journal of medicine.

[8]  J. Beckmann,et al.  A linkage map of human chromosome 15 with an average resolution of 2 cM and containing 55 polymorphic microsatellites. , 1993, Human molecular genetics.

[9]  E. Engel,et al.  Uniparental disomy revisited: the first twelve years. , 1993, American journal of medical genetics.

[10]  R. Nicholls,et al.  Genomic imprinting and uniparental disomy in Angelman and Prader-Willi syndromes: a review. , 1993, American journal of medical genetics.

[11]  M. Vekemans,et al.  Trisomy 15 in chorionic villi and Prader‐Willi syndrome at birth , 1993, Prenatal diagnosis.

[12]  M. Butler,et al.  Prader-Willi syndrome: consensus diagnostic criteria. , 1993, Pediatrics.

[13]  D. Ledbetter,et al.  Multiplex PCR of three dinucleotide repeats in the Prader-Willi/Angelman critical region (15q11-q13): molecular diagnosis and mechanism of uniparental disomy. , 1993, Human molecular genetics.

[14]  C. Bennett,et al.  Trisomy 15 mosaicism in an IVF fetus. , 1992, Journal of medical genetics.

[15]  R. Erickson,et al.  Trisomy 15 with loss of the paternal 15 as a cause of Prader-Willi syndrome due to maternal disomy. , 1992, American journal of human genetics.

[16]  A. Jeffreys,et al.  The frequency of uniparental disomy in Prader-Willi syndrome. Implications for molecular diagnosis. , 1992, The New England journal of medicine.

[17]  S. Purvis-Smith,et al.  Uniparental disomy 15 resulting from "correction" of an initial trisomy 15. , 1992, American journal of human genetics.

[18]  J. Lähdetie,et al.  Mosaic trisomy 15 found at amniocentesis , 1992, Prenatal diagnosis.

[19]  D. Ledbetter,et al.  Cytogenetic results from the U.S. collaborative study on CVS , 1992, Prenatal diagnosis.

[20]  A. Prader,et al.  Molecular, cytogenetic, and clinical investigations of Prader-Willi syndrome patients. , 1991, American journal of human genetics.

[21]  E. Engel,et al.  Uniparental disomy, isodisomy, and imprinting: probable effects in man and strategies for their detection. , 1991, American journal of medical genetics.

[22]  J. Hall,et al.  Genomic imprinting: review and relevance to human diseases. , 1990, American journal of human genetics.

[23]  H. Wallenburg,et al.  LOW-DOSE ASPIRIN PREVENTS PREGNANCY-INDUCED HYPERTENSION AND PRE-ECLAMPSIA IN ANGIOTENSIN-SENSITIVE PRIMIGRAVIDAE , 1986, The Lancet.

[24]  J. Semmens,et al.  A case of trisomy of chromosome 15 , 1981, Journal of medical genetics.

[25]  D. Ledbetter,et al.  Molecular characterization of two proximal deletion breakpoint regions in both Prader-Willi and Angelman syndrome patients. , 1995, American journal of human genetics.

[26]  G. Gimelli,et al.  Prenatal diagnosis, fetal pathology and cytogenetic analysis of A 46,XX/47,XX, + 15 mosaic , 1983, Prenatal diagnosis.